EPILEPSY, SCHIZOPHRENIA, AND SODIUM-POTASSIUM-A.T.P.ASE
- 1 April 1972
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 299 (7753) , 749
- https://doi.org/10.1016/s0140-6736(72)90266-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Inhibition by chlorpromazine of the effects of dopamine on the dog kidneyJournal of Pharmacy and Pharmacology, 1970
- CHEMICAL BASIS OF EPILEPSYThe Lancet, 1970
- Studies on the Mechanism of Action of DiphenylhydantoinArchives of Neurology, 1970
- Inhibition of sodium-potassium activated brain adenosine triphosphatase (Na+ - K+-ATPase) by adrenergic blocking alkylating agentsLife Sciences, 1969
- EPILEPSY AND SCHIZOPHRENIA RELATIONSHIP AND BIOCHEMISTRYThe Lancet, 1968
- Poisoning by venomous animalsThe American Journal of Medicine, 1967
- The mechanism of action of anticonvulsants. I. DiphenylhydantoinLife Sciences, 1965
- Sodium – Potassium-activated Adenosine Triphosphatase in Schizophrenic ErythrocytesNature, 1963
- Properties and possible mechanism of the Na+ and K+-stimulated microsomal adenosinetriphosphataseBiochimica et Biophysica Acta, 1962
- THE NEPHROTIC SYNDROME IN ADULTS: A COMMON DISORDER WITH MANY CAUSESAnnals of Internal Medicine, 1958